X.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Total Revenue

Revenue analysis for XTLB.

Quarterly Revenue

$289000.00

As of Dec 2024

Annual Revenue (TTM)

$451000.00

Trailing 12 months ending Dec 2024

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin